Table 1.
Characteristics of 10,985 HIV-infected patients in routine care at CNICS sites in the United States at baseline and over follow-up: 2005–2014.
| Characteristic | Baseline (n=10,985) | Follow-up (over 99,040 observed PROs4, representing 35,621 person-years) |
|---|---|---|
|
| ||
| N(%) or Median (IQR) | N(%) or Median (IQR) | |
| Age | 44 (36, 50) | -- |
| Gender | ||
| Male | 9,324 (84.9) | -- |
| Female | 1,660 (15.1) | -- |
| Race/ethnicity | ||
| White, non-Hispanic | 5,546 (50.9) | -- |
| Black, non-Hispanic | 3,178 (29.2) | -- |
| Hispanic | 1,680 (15.4) | -- |
| Other | 488 (4.5) | -- |
| HIV acquisition risk group | ||
| IDU 1 | 1,538 (14.2) | -- |
| MSM 2 | 6,843 (63.0) | -- |
| Heterosexual | 2,313 (21.3) | -- |
| Other | 173 (1.6) | -- |
| Depressive symptoms | 5 (1,10) | 4 (0, 9) |
| No depressive symptoms (PHQ-9 <10) | 7,962 (72.5) | 60,334 (60.9) |
| Depressive symptoms (PHQ-9 ≥10) | 3,023 (27.5) | 38,706 (39.1) |
| On antidepressants | ||
| No | 8,255 (75.8) | 71,162 (72.0) |
| Yes | 2,643 (24.2) | 27,645 (28.0) |
| Alcohol use | ||
| Not high risk | 7,553 (72.3) | 73,217 (77.1) |
| High Risk | 2,893 (27.7) | 21,789 (22.9) |
| Drug use (excluding marijuana) | ||
| No use | 4,527 (43.9) | 47,638 (50.8) |
| Current use | 1,875 (18.2) | 12,377 (13.2) |
| Past use | 3,916 (38.0) | 33,718 (36.0) |
| Panic disorder | ||
| No panic symptoms | 7,544 (70.2) | 70,650 (72.9) |
| Some panic symptoms | 1,701 (15.8) | 13,657 (14.1) |
| Panic disorder | 1,503 (14.0) | 12,627 (13.0) |
| Mental health diagnosis prior to baseline | ||
| 0 | 10,342 (94.1) | -- |
| ≥ 1 | 643 (5.9) | -- |
| ART use/adherence 3 | ||
| ART, adherent | 6,996 (63.7) | 70,714 (77.5) |
| ART, not adherent | 1,358 (12.4) | 12,556 (13.8) |
| Not on ART | 2,631 (24.0) | 7,953 (8.7) |
| CD4 count | 479 (303, 684) | 495 (309, 699) |
| Viral load suppression (<50 copies/mL) | ||
| Undetectable | 5,506 (55.4) | 57,300 (64.9) |
| Detectable | 4,436 (44.6) | 31,044 (35.1) |
1
IDU = Intravenous drug users,
2
MSM = men who have sex with men,
3
adherence defined as no missed doses in the last week,
4
PRO = patient reported outcome. Missing baseline data: age n=1, race/ethnicity n=93, HIV acquisition risk group n=118, on antidepressants n=87, alcohol use n=539, drug use n=667, panic disorder n=237, viral load suppression n= 1,043.